Phase 3 Bipolar Disorder Trial, Recruiting NCT07412132 Sponsor: University of Sao Paulo Condition: Bipolar Disorder
Back to Bipolar Disorder

Phase 3 Bipolar Disorder Trial, Recruiting

NCT07412132
Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with bipolar disorder (either type I or type II), confirmed through a structured clinical interview
  • You are currently going through a moderate or severe depressive episode related to your bipolar disorder
  • At least two different medication treatments for your current depressive episode have not worked adequately

Who may not be able to join:

  • You have a current diagnosis of schizophrenia, dementia, an intellectual disability, or a brain-related mental health condition caused by a physical illness (note: having additional conditions such as anxiety disorders, personality disorders, substance use disorders, eating disorders, or attention deficit disorder is generally allowed, as long as bipolar disorder is your main diagnosis)
  • You are currently having serious thoughts of suicide (confirm with trial site)
  • Your current depressive episode includes symptoms such as hallucinations or delusions
  • You are pregnant or think you might be pregnant
  • You have a serious or unstable physical health condition
  • You have previously tried a full course of electroconvulsive therapy (ECT) — typically at least 8 sessions — and it did not help you
  • You have previously tried a full course of ketamine treatment and it did not help you

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: +55 11 2661-6648

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Registry
ClinicalTrials.gov
Start date
9 January 2026
Est. completion
1 January 2027

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Primary outcome

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov